HOOKIPA Pharma Inc.

NASDAQ: HOOK · Real-Time Price · USD
0.83
-0.01 (-1.19%)
At close: Aug 15, 2025, 1:55 PM
0.83
0.00%
After-hours: Aug 15, 2025, 01:55 PM EDT

HOOKIPA Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-15.43M -24.95M -13.84M -19.09M 14.38M -24.82M -19.07M -18.02M -19.68M -12.31M -18.28M -16.36M -17.97M -21.23M -20.04M -17.15M -17.24M
Depreciation & Amortization
389K 699K 700K 714K 640K 1.28M 487K 866K 921K 904K 760K 860K 1.08M 1.23M 1.09M 1.22M 1.1M
Stock-Based Compensation
-353K 865K 939K 459K -249K 417K 574K 696K 658K 1M 1.04M 1.38M 1.62M 1.78M 1.72M 2.63M 1.52M
Other Working Capital
n/a -4.46M 35.21M -4.09M -26.59M -8.16M -6.06M -2.31M 7.55M 32.7M -3.42M -3.3M 12.47M 3.37M -588K -482K -882K
Other Non-Cash Items
n/a 3.83M -40.69M 459K 13.38M 8.56M n/a 838K 4K 172K -168K 82K 74K 1.19M 1K 33K 2.23M
Deferred Income Tax
n/a n/a n/a n/a n/a 4.26M n/a -838K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -1.38M 35.38M 3.55M -38.93M -927K -6.11M -2.88M 15.25M 23.37M 140K -4.33M 16.93M 3.79M -416K -7.46M 217K
Operating Cash Flow
52K -20.94M -17.51M -14.38M -24.16M -11.22M -24.12M -19.33M -2.85M 13.14M -16.51M -18.36M 1.73M -13.24M -17.64M -20.73M -14.4M
Capital Expenditures
-20K -2K -31K -45K -116K -422K -3.02M -445K -274K -599K -958K -1.63M -1.83M -5.14M -2.49M -4.62M -330K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-20K -2K -31K -45K -116K -422K -3.02M -445K -274K -599K -958K -1.63M -1.83M -5.14M -2.49M -4.62M -330K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a -1.16M -597K -1K 125K -2.95M -20K -374K -13K -27K -24K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -395K n/a n/a n/a n/a n/a n/a n/a -237K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a -1.14M -135K 21.25M -1K -9K -139K -195K n/a n/a n/a -36K n/a n/a n/a
Financial Cash Flow
n/a n/a n/a -1.14M -135K 21.25M -659K 45.81M -735K -196K 127K -2.95M 75.29M -410K -11K 85K 101K
Net Cash Flow
594K -20.07M -17.4M -15.6M -24.34M 9.42M -27.91M 25.99M -3.42M 12.77M -18.18M -22.94M 74.89M -15.79M -20.26M -25.19M -15.03M
Free Cash Flow
32K -20.94M -17.54M -14.42M -24.27M -11.65M -27.14M -19.78M -3.12M 12.54M -17.47M -19.99M -95K -18.38M -20.13M -25.36M -14.73M